Growth-hormone signaling
Tesamorelin: Uses, Side Effects and Safety
Growth hormone-releasing factor analog; prescription medicine.
Overview
Tesamorelin is a synthetic peptide analog of growth hormone-releasing factor. The U.S. label describes a narrow use in adults with HIV-associated lipodystrophy.
How it works
It stimulates endogenous growth-hormone release. Its label-specific use should not be generalized to ordinary weight management, bodybuilding, or anti-aging.
Uses described in the source
The cited 2024 Egrifta SV U.S. label indicates tesamorelin to reduce excess abdominal fat in adults with HIV-associated lipodystrophy and explicitly says it is not indicated for weight-loss management. Verify the latest label.
Evidence
Human evidence for a narrow, labeled indication
Regulatory status
The cited Egrifta SV label is a U.S. FDA label for a specified indication. It does not establish approval or availability in Colombia, or availability through YouMedicine.
Safety
The label lists contraindications and risks, including active malignancy and changes in glucose metabolism. Review the complete current label with a licensed clinician.
YouMedicine availability
Educational listing only. YouMedicine availability has not been confirmed.
Sources
The narrow labeled indication must not be extrapolated to general weight loss, performance, or longevity claims.